Target intelligence / Profile preview

16S ribosomal RNA decoding A-site (16S rRNA A-site)

Target
16S rRNA A-site
Molecular classification
Ribosomal RNA, Ribonucleic acid, Bacterial ribosome component
01

Overview

The 16S ribosomal RNA (rRNA) decoding A-site is a highly conserved functional region within the 30S small ribosomal subunit of bacteria [1, 4]. Its primary biological role is to ensure the accuracy of protein synthesis by monitoring the base-pairing between the mRNA codon and the aminoacyl-tRNA anticodon [2, 9]. During translation, specific nucleotides (A1492 and A1493) flip out of the rRNA helix to stabilize the codon-anticodon interaction, a process essential for the selection of the correct tRNA [8, 9]. This site is the principal target for aminoglycoside antibiotics, which bind with high affinity to the internal loop of the A-site [1, 5]. By locking the decoding center in an "active" conformation regardless of the tRNA match, these drugs induce widespread mistranslation and inhibit translocation, leading to the production of toxic, misfolded proteins and bacterial cell death [3, 5]. Resistance to these drugs often arises through enzymatic modification of the rRNA by methyltransferases or through specific mutations that reduce drug binding affinity [1, 2].

Other names
16S rRNA decoding region30S A-siteAminoacyl-tRNA binding siteDecoding center16S rRNA aminoacyl-tRNA binding site
02

Mechanism of action

Aminoglycosides bind to the A-site of the 16S rRNA, inducing a conformational change in nucleotides A1492 and A1493. This change mimics the state of a correct codon-anticodon match, leading to the incorporation of incorrect amino acids (mistranslation) and the inhibition of ribosomal translocation, which ultimately results in bacterial cell death [1, 2, 5].

03

Biological functions

Protein synthesisTranslationmRNA decodingtRNA binding
04

Disease associations

Infection
05

Safety considerations

OtotoxicityNephrotoxicityNeuromuscular blockadeCross-reactivity with human mitochondrial 12S rRNA
06

Interacting drugs

Amikacin

10 more in the full profile.

07

Biomarkers

16S rRNA methyltransferases (e.g., ArmA, RmtA, RmtB)16S rRNA gene mutations (e.g., A1408G)Minimum Inhibitory Concentration (MIC)

Beyond the preview

Go deeper on 16S ribosomal RNA decoding A-site (16S rRNA A-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 16S ribosomal RNA decoding A-site (16S rRNA A-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call